Global Ganja Report

The cannabis prohibition regime in South Korea is a harsh one. Authorities have long been intent on maintaining the official fiction of a "drug-free" nation. But the first crack has appeared in this intolerant edifice, with lawmakers and bureaucrats now moving to approve use of certain imported medical marijuana products.

Amid the various protesters that announced plans to gather in Washington DC as Trump held his military parade on Veterans' Day weekend, a group of military vets say they will be camping out at the national offices of the Veterans Administration—to demand access to medical marijuana, as well as protest budget cuts at the agency.

The case of an elderly grandmother who was jailed for cannabis possession because her Michigan state medical marijuana card had expired exemplifies the dilemmas faced by patients who fall between cracks in the bureaucracy. Keeping paperwork in order can be a challenge for those already burdened with disabling health conditions.

A parliamentary initiative has been launched to legalize medical marijuana cultivation in fabled hashish producer Lebanon, amid growing proposals for a general legalization of cannabis. But many growers in the Bekaa Valley are watching warily, fearing they will be left behind as foreign capital flows in for a legal industry.

The Oklahoma Board of Health has issued new rules to oversee the state's medical marijuana program, and advocates are relieved that the ban on smokable herbaceous cannabis has been removed. However, concerns remain about other restrictions that could make it essentially impossible for cannabis business to function in the state.

After three years of mounting discontent from patients and providers alike, Florida's medical marijuana chief Christian Bax is stepping down. He leaves office as state health authorities prepare for a tsunami of applications for a few highly coveted marijuana licenses.

Israel's Knesset overwhelmingly passed a cannabis decriminalization measure—sponsored by the ruling conservative government. This fruit of a long campaign by activists is, however, tentative. The law is set to expire in three years, pending a review of the policy's impacts.

The British government has finally capitulated to pressure from patients, activists and even regional authorities, and officially pledged to make medical cannabis products available on prescription this year. But it remains to be seen which products will win approval—and actual herbaceous cannabis is unlikely to make the cut.